Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) FCF Margin (2016 - 2025)

Surgery Partners (SGRY) has disclosed FCF Margin for 12 consecutive years, with 10.24% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 7.0% to 10.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.91% through Dec 2025, down 82.0% year-over-year, with the annual reading at 5.91% for FY2025, 82.0% down from the prior year.
  • FCF Margin hit 10.24% in Q4 2025 for Surgery Partners, up from 7.77% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 12.71% in Q3 2023 to a low of 2.19% in Q4 2022.
  • Historically, FCF Margin has averaged 4.91% across 5 years, with a median of 5.83% in 2024.
  • Biggest five-year swings in FCF Margin: plummeted -4845bps in 2021 and later soared 1072bps in 2023.
  • Year by year, FCF Margin stood at 0.92% in 2021, then plummeted by -339bps to 2.19% in 2022, then skyrocketed by 366bps to 5.82% in 2023, then soared by 77bps to 10.31% in 2024, then fell by -1bps to 10.24% in 2025.
  • Business Quant data shows FCF Margin for SGRY at 10.24% in Q4 2025, 7.77% in Q3 2025, and 7.01% in Q2 2025.